SAN CARLOS, Calif., May 08, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the AVANCE™ steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including […]
Other News
SentiAR Names Berk Tas President and CEO
ST. LOUIS, May 8, 2019 /PRNewswire/ — SentiAR, a medical device startup transforming the cardiac ablation procedures, today announced that industry expert Berk Tas has joined the company as CEO and president. Tas brings to SentiAR over a decade in the healthcare medical device industry at both large organizations and startups. Tas has […]
Study Finds Micro-AF is a Predictor of Clinical AF, Provides Guidance on ECG Monitoring Duration
PLANO, Texas, May 8, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC today announced new research connecting short episodes of Atrial Fibrillation called micro-AF (4 beats <29) with the presentation of clinical AF (>30 seconds). The study showed that 83% of patients with micro-AF also had a clinical AF episode during prolonged registration, and […]
Radcliffe Group Ltd Appoints Non-Executive Chairman and Chief Scientific Officer
LONDON, May 8, 2019 /PRNewswire/ — Radcliffe Group Ltd (“RG”) announces Professor Andrew Coats (recently Academic Vice President, Monash University and University of Warwick) as Non-Executive Chairman and Dr. Gregory Guillory as Chief Scientific Officer, effective on April 1, 2019. Professor Andrew Coats (top right) is a world-renowned Australian–British academic cardiologist who has a particular interest in the management of heart failure. His research […]
Correvio Reports First Quarter 2019 Financial Results
VANCOUVER, May 8, 2019 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today reported financial results for its first quarter ended March 31, 2019 and commented on recent accomplishments and plans. “2019 is off to a strong start with first quarter revenues up 16% year-over-year in […]
Preventice Solutions Presents Real-World Performance of Wearable ECG Monitoring Technology using Deep Learning Algorithms for Detecting Atrial Fibrillation
MINNEAPOLIS, May 8, 2019 /PRNewswire/ — At Heart Rhythm 2019, the Heart Rhythm Society’s 40th Annual Scientific Sessions, Preventice Solutions will present clinical data validating its BodyGuardian® Remote Monitoring System with the BeatLogic™ deep learning platform. This technology leverages machine learning and artificial intelligence (AI) for detection of atrial fibrillation (AF) and was validated using […]
Impulse Dynamics Announces Successful Implantation of First Patient Since FDA Approval of Optimizer® Smart System
NEW YORK, May 8, 2019 /PRNewswire/ — Impulse Dynamics, developer of the implantable Optimizer® Smart System for delivering CCM™ therapy, announced today that the first patient to receive the Optimizer Smart System since the device was approved by the U.S. Food and Drug Administration was successfully implanted. The procedure, which occurred on Monday, May […]
BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing
MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s Tempo® Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing. BioTrace Medical’s Tempo Temporary Pacing Lead is designed for safer, more secure and stable pacing to […]
FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System
MENLO PARK, CA, May 8, 2019 /PRNewswire/ – FARAPULSE Inc. (“FARAPULSE” or “the “Company”) today announced it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) for its Endocardial Ablation System. The system is being developed to advance the […]
INTELLIGENT DATA ANALYTICS SOFTWARE SOLUTION COMES TO ELECTROPHYSIOLOGY WITH LAUNCH OF BIOSENSE WEBSTER’S CARTONET
San Francisco– May 7, 2019 – Johnson & Johnson Medical Devices Companies* today announced the launch of Biosense Webster, Inc.’s CARTONET as part of the company’s mission to help revolutionize the way electrophysiologists, hospitals, health systems, and researchers leverage and share data with the goal of improving patient outcomes and […]
Recent
Da Vinci 5 Cleared for Cardiac Procedures
Milestone Pharmaceuticals Announces U.S. Availability of CARDAMYST™ (etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES
Popular
- No commented posts yet